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Community use of facemasks and similar barriers to prevent 
respiratory illness such as COVID-19: A rapid scoping review 
 
 
Background:  Evidence for facemask wearing in the community to protect against respiratory 
disease is unclear. 
 
Aim: To assess efficacy of wearing facemasks in the community to prevent respiratory disease, and 
recommend improvements to this evidence base.  
 
Methods: We systematically searched Scopus, Embase and MEDLINE for studies evaluating 
incidence of respiratory disease after facemask wearing (or not).  Narrative synthesis and random-
effects meta-analysis of attack rates for primary and secondary prevention were performed, 
subgrouped by design, setting, type of face barrier, and who wore the facemask. Preferred outcome 
was influenza-like illness.  GRADE quality assessment was undertaken and evidence base deficits 
described. 
 
Results:   33 studies (12 RCTs) were included.  Mask-wearing reduced primary infection by between 
6% (in RCTs, OR 0.94, 95%CI 0.75-1.19) and 61% (cohort studies OR 0.85, 95%CI 0.32 to 2.27; case 
control studies OR 0.39, 95%CI 0.18-0.84; cross-sectional studies OR 0.61, 95%CI 0.45-0.85).  RCTs 
suggested lowest secondary attack rates when both well and ill house-hold members wore masks 
(OR 0.81, 95%CI 0.48 - 1.37).  While poor compliance and controls wearing masks probably 
underestimated effects in RCTs, effects are likely overestimated in observational studies where mask 
wearing is associated with other risk-averse behaviours.  GRADE was low or very low quality. 
 
Conclusion:  Wearing facemasks may reduce risk of primary respiratory infection, probably by 6-
15%.  This review raises significant issues about balancing evidence from RCTs and observational 
studies when these give very different conclusions and both observational studies and RCTs are at 
risk of significant bias. Studies specifically addressing COVID-19 infection are required. 
 
Keywords:  Coronavirus, facemask, influenza-like-illness, Hajj, respiratory infection 
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INTRODUCTION 
On 30 January 2020 the World Health Organisation (WHO) declared a Public Health Emergency of 
International Concern (PHEIC) in response to the emergence of a novel coronavirus in Wuhan, China 
[1].    On the 11th March 2020 the WHO declared the COVID-19 epidemic to be a pandemic [2].  By 
the end of June 2020 nearly 500,000 global deaths had been linked to COVID-19 [3].  It is not clear 
when this outbreak will abate.  
 
Amongst other advice widely sought by the public in response to this outbreak, was whether 
wearing face coverings, especially medical-grade coverings (e.g. masks, goggles or similar) might 
reduce the risk of catching or transmitting disease [4], particularly in domestic and public places.  
Sales of inexpensive facemask products soared following the PHEIC declaration, leading to potential 
shortages for health care workers [5-10].  Previous systematic reviews on the efficacy of using 
facemasks in community settings assessed facemasks combined with other personal protection 
measures [11-13] or mixed health care workers with non-health care workers [12, 14-16]. Those that 
specifically examined community use had focused only on RCTs [17, 18]. Overall, the reviews had 
mixed conclusions about community settings: that facemasks were highly effective [12, 16], 
definitely effective [14, 19], may be effective for protection [17, 18, 20] or did not have a statistically 
significant effect [12]. There has been near consensus that the evidence base is inadequate [11, 14, 
17-20].  
 
We responded to this information demand by undertaking a rapid systematic review to evaluate 
evidence that might indicate the effectiveness of wearing facemasks in the community in relation to 
the transmission of respiratory disease. This review therefore considers the quality of the evidence 
for these outcomes and produces recommendations on how to improve this evidence base. 
 
 
METHODS 
Review aims  
We aimed to assess the effectiveness of wearing a face barrier (mask, goggles, shield, veil) in 
community settings to prevent transmission of respiratory illness, such as from coronaviruses, 
rhinoviruses, influenza viruses or tuberculosis, and recommend how to improve this evidence base.  
We use the words mask and facemask interchangeably as umbrella terms for diverse facial coverings 
that may cover any combination of mouth, nose and/or eyes.   
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Search Strategy 
Two recent literature reviews [12, 18] were consulted to find eleven exemplar studies [21-31] that 
met our eligibility criteria.   We designed search strategies that were sensitive enough to find these 
exemplar studies and similar research, yet specific enough exclude most irrelevant records.  The 
bibliographic databases Scopus, Embase and Medline were searched with the phrases in Box 1.   We 
read other systematic reviews [11, 12, 14, 16-20] on similar non-pharmaceutical practices to look for 
any missing primary studies.  
 
Assessment of inclusion 
Two authors (JB, NJ or IL) independently screened the retrieved titles and abstracts.  Disagreements 
were resolved by discussion with other authors.  The inclusion criteria were: 
 
• Original research (not a review, guidelines, discussion, regulations, debate or commentary) 
published in English since January 1980 
• The research needed to describe facemask use that might prevent disease transmission or 
symptom development among people in the community (rather than prevent transmission 
to or from professionals in clinical settings) 
• The study described an observed relationship between facemask use and respiratory 
symptoms or infection by respiratory pathogens: (e.g. influenza, coronavirus, tuberculosis).   
• There was a comparator or control group (non-barrier users) for whom disease incidence 
data were also collected 
• Any study design in any country, as long as comparator data were available 
 
The full text of each article that passed screening was retrieved and eligibility verified as part of data 
extraction. 
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Data Extraction for efficacy 
Characteristics of included studies, qualitative data and numbers of participants who developed 
respiratory outcomes in relevant study arms were extracted.  The preferred specific outcome was 
influenza-like illness (ILI), defined by WHO as fever ≥ 38 C° with cough and onset ≤ 10 days previous 
[32]. Where a WHO-definition was unavailable, we accepted other similar case definitions (e.g. cold 
symptoms, acute respiratory infections, clinical cases of influenza or SARS) so that we could expand 
the evidence base and because of the often reported ‘atypical’ presentations and disease courses of 
COVID-19 [33].  Where studies reported three arms we extracted data for arms where the only 
difference was whether a facemask was worn (e.g. hand hygiene and no masks vs. hand hygiene + 
facemasks).   
 
Synthesis of evidence on effectiveness 
Characteristics of included studies were tabulated.  Numbers of infections and numbers of people at 
risk in each study arm were input to Review Manager 5.3 [34] for meta-analysis by JB, verified by 
other authors.  We calculated pooled odds ratios using Mantel-Haenszel random effects meta-
analysis (due to expected high heterogeneity) separately for primary prevention (when no cases 
were yet been identified) and prevention of secondary cases (when an individual was diagnosed with 
an infection and the aim was to prevent contacts from getting disease).  We subgrouped by study 
design (RCT, cohort, case control or cross-sectional), and presented these subgroups in forest plots 
without global pooling to understand consistency of evidence across study designs. We also showed 
the trend of evidence within settings (subgrouping by setting).  For secondary transmission (in RCTs) 
BOX 1 Bibliographic database search phrases 
 
SCOPUS  
TITLE-ABS-KEY (  
(facemask?  OR  "facemasks?"  OR  mask?  OR  goggle?  OR  faceshield?  OR  respirator  OR  respirators)  
AND   
(influenza  OR  flu  OR  sars  OR  tuberculosis  or mers OR  coronav*  OR  “cov”  OR  respiratory-
syndrome  OR  wuhan or “ncov”) 
 )   
AND   
( LIMIT-TO ( SUBJAREA ,  "MEDI" )  OR  LIMIT-TO ( SUBJAREA ,  "NURS" )  OR  LIMIT-TO ( SUBJAREA ,  "IMMU" ) ) 
 
EMBASE & Medline via OVID 
[(facemask* or "face-mask*" or mask* or goggle* or face-shield* or respirator or respirators).kw,ti,ab.] 
and 
[(influenza or flu or sars or tuberculosis or mers or coronav* or "cov" or respiratory-syndrome or "ncov" or 
wuhan).kw,ti,ab.] 
  
5 
 
we subgrouped by who wore the facemask: index case, well contacts of the index case, or both.  
Outcomes after wearing faceveils were also presented where evidence was available. 
 
Quality of evidence  
Risk of bias of included RCTs was assessed (by LH) using the Cochrane risk of bias tool [35], and 
biases and limitations identified by primary study authors of observational studies were noted.  We 
assessed the quality of evidence using the GRADE framework, based on the RCT data and supported 
or contradicted by observational data [35].   To further evaluate the translational value of the 
evidence, we report narratively on other aspects of the studies.  Compliance or contamination in 
RCTs was noted, along with any information about what kinds of masks controls wore as part of the 
contamination.  Formal quality assessment checklists were not undertaken for observational studies, 
but we noted the kinds of masks worn (if reported).  For all primary studies, settings and outcomes 
were recorded and are discussed with respect to their relevance to aspects of COVID-19 outbreak 
control. For all primary studies, we noted limitations as reported by the original investigators and 
discuss narratively any general limitations these imply for the wider evidence base. 
 
 
RESULTS 
Study selection and overview 
Figure 1 shows the study selection process.   Study characteristics are shown in Table 1.   GRADE 
assessments are shown in Table 2.  The search was updated through 19 June 2020. Altogether, 1233 
titles and abstracts were retrieved from Scopus, and 1657 from Embase with Medline. Our search 
located all 11 exemplar articles. Combining and deduplicating left 2081 articles. Of these 236 were 
not written in English and 81 were published before 1980, so were removed. This left 1764 titles and 
abstracts to screen, of which 47 were selected to be collected in full text.  Full text review identified 
26 eligible studies.  Checking other systematic reviews on protective effects of facemask use in the 
community identified a further seven studies (five in the Hajj setting and two in other community 
settings).  The specific mask types were mostly unspecified, but where specified they were surgical 
medical grade items (n=14).  Of the 33 included studies, 12 were designed as cluster-RCTs, five were 
cohort studies, six were case control and 10 were cross-sectional.  Data suitable for meta-analysis 
were reported in 31 studies. Settings included schools, university residences, visits to health care 
providers, family households, the Hajj mass gathering, and non-specific community places. Most 
studies reported on influenza-like illness (ILI) as an outcome (n=14) or respiratory illness (n=10).  
Fever with respiratory symptoms, upper respiratory tract infection, lab-confirmed or clinical 
6 
 
influenza, toxic pneumonitis, common colds, other respiratory symptoms, evidence of immunity to 
SARS-CoV from serology and positive rt-PCR results for SARS-CoV-2 were also used as dichotomous 
outcomes when ILI was unavailable. All mass gathering studies were associated with the Hajj 
pilgrimage. Table S1 lists additional characteristics of the included studies.  
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Table 1.   Setting, study design and outcome for each included study. 
 
Study Setting Design Outcome Comparison 
Aiello 2010 
pilot [21] 
University residences cluster RCT 'fever' symptoms Allocated arms 
Aiello 2012 
[22] 
University residences cluster RCT ILI symptoms Allocated arms 
Alfelali 2019 
as RCT [36] 
Hajj pilgrimage cluster RCT respiratory illness Allocated arms 
Alfelali 2019  
[36]  
Hajj pilgrimage as cohort respiratory illness Used facemask 
daily or not 
Al-Jasser 2012 
[37] 
Hajj pilgrimage cross sectional respiratory illness Most of the time 
vs. 
sometimes/never 
Balaban 2012 
[38] 
Hajj pilgrimage retrospective 
cohort 
respiratory illness Had facemask 
practice or not 
Barasheed 
2014 [39] 
Hajj pilgrimage, pilgrims 
sleeping near index cases 
cluster RCT respiratory illness Allocated arms 
Canini 2010 
[23] 
Household with index case 
wearing mask who had been 
symptomatic < 48 hrs 
cluster RCT ILI Allocated arms 
Choudhry 
2006 men [40] 
Hajj pilgrimage (males) prospective 
cohort 
respiratory illness Most of time vs. 
sometimes/never 
Choudhry 
2006 women 
[40] 
Hajj pilgrimage (female) prospective 
cohort 
respiratory illness Most of the time 
vs. 
sometimes/never 
Cowling 2008 
[25] 
Household, wearing masks 
soon after index case flu test 
cluster RCT ILI Allocated arms 
Cowling 2009 
[24] 
Household, wearing masks 
soon after index case flu test 
cluster RCT ILI Both arms also 
had hand hygiene 
intvn 
Deris 2010 
[41] 
Hajj pilgrimage cross-sectional ILI  Allocated arms 
Emamian 2013 
[42]  
Hajj pilgrimage nested case 
control 
respiratory illness (not 
colds) 
Wore a mask or 
not 
Fan 2020 [43] Chinese citizens (82% 
students) living in Iran and 
subsequently evacuated  
cohort confirmed SARS-CoV-2  Wore a mask or 
not before left 
Iran 
Hashim 2016 
[44] 
Hajj pilgrimage cross-sectional respiratory illness Used or not; 
multiple types of 
face cover used 
Jolie 1998 [45] Pig farm, visiting students cross-sectional respiratory symptoms During visit or not 
Kim 2012 [46] Schools cross-sectional Lab-confirmed influenza Continuous or 
irregular vs. non-
users 
Larson 2010 
[26] 
Care settings cluster RCT ILI Allocated arms 
Lau 2004a [28] Public places, visitors case control ILI = suspected SARS Frequently vs. 
seldom/no 
Lau 2004b [27] Hospital, visitors to SARS 
index cases  
case control ILI = suspected SARS During visit or not  
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MacIntyre 
2009 [29] 
Household, adults wear 
mask caring for sick child 
cluster RCT ILI Allocated arms 
MacIntyre 
2016 [47] 
Household, index case 
wearing mask when 
symptomatic <24 hrs 
cluster RCT ILI Allocated arms 
Shin 2018 
control [48] 
Community cohort common cold symptoms Habitually wearing 
a facemask or not 
Shin 2018 
intvn arm [48] 
Community cohort common cold symptoms Habitually wearing 
a facemask or not 
Simmerman 
2011 [30] 
Household cluster RCT ILI Allocated arms 
Suess 2012 
[31] 
Household, members 
wearing masks when index 
case symptomatic <48 hrs 
cluster RCT ILI Allocated arms 
Tahir 2019 
[49] 
Poultry farm, workers cross-sectional serological tests for 
A(H9N2) influenza 
Always vs. 
sometimes/never
  
Tuan 2007 
[50] 
Households with lab-
confirmed SARS case 
cohort SARS-CoV-1 positive 
serology 
Sometimes/mostly 
vs. never 
Uchida 2017 
[51] 
Schools cross-sectional influenza Mask wearing 
ever vs. never 
Wu 2004 [52] Community case control SARS (WHO case 
definition) 
Always vs. 
sometimes/never 
Wu 2016 [53] Hospital, visitors without 
contact with known case 
cross-sectional ILI Habitually or not 
Zein 2002 [54] Hajj pilgrimage, masks 
supplied for all 
cross-sectional URTI symptoms Used masks or not 
Zhang 2013a 
[55] 
Long-haul flights case control ILI linked to H1N1 (WHO 
case definition) 
Wore mask for 
entire flight or not 
Zhang 2013b 
[56] 
Households, self-quarantine 
with index patient 
case control lab-confirmed influenza 
(H1N1) 
Daily mask 
wearing or not 
 
 
Abbreviations: ILI  = influenza-like illness, intvn = intervention, RCT= randomised controlled trial,  
URTI=upper respiratory tract infection, WHO = World Health Organisation. 
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 Table 2. Summary of GRADE findings   
 Masks compared to no masks for influenza-like illness 
 Patient or population: people without ILI, either in contact with a person with ILI (secondary transmission) or not (primary 
prevention).  Setting: Any.  Intervention (or exposure): Advice to wear a mask and/or provision of masks (or wearing a mask).  
Comparison: No advice to wear a mask/advice to not wear masks (or not wearing a mask). 
Setting (outcome 
always ILI) 
 Anticipated absolute 
effects* (95% CI)  
Relative effect 
(95% CI)  
№ of 
participants  
(studies)  
Quality  
of the 
evidence 
(GRADE)  
Comments Study type  Risk 
without 
masks 
Risk with 
masks 
Primary prevention, 
well wear masks  
 
  
RCTs 108 per 
1,000  
102 per 1,000 
(83 to 125)  
OR 0.94 
(0.75 to 1.19)  
5183 
(3 RCTs)  
⨁⨁◯◯ 
LOW 
a,b,c,d,e 
Wearing a mask may very slightly 
reduce the odds of primary infection 
with influenza-like illness (ILI) by 
around 6 to 15%. Low-quality evidence 
(downgraded once each for risk of bias 
and imprecision).  
Cohort studies 197 per 
1,000 
141 per 1,000 OR 0.85  
(0.32 to 2.27) 
5217  
(7 cohorts) 
Case control 
studies 
405 per 
1,000 
184 per 1,000 OR 0.39  
(0.18 to 0.84) 
1501  
(4 studies) 
Cross- 
sectional 
341 per 
1,000 
223 per 1,000 OR 0.61  
(0.45 to 0.85) 
10,058  
(8 studies)  
Secondary 
transmission, use of 
masks in homes, only 
ill person wears mask  
RCTs 
68 per 
1,000  
 
65 per 1,000 
(38 to 108)  
OR 0.95 
(0.53 to 1.72)  
903 
(2 RCTs)  ⨁◯◯◯ 
VERY 
LOW f,g  
When one household member becomes 
ill with an ILI the effect of their wearing 
a mask on the odds of house-mates 
developing ILI is unclear, as the evidence 
is of very low quality (downgraded once 
for risk of bias, twice for imprecision). 
Case control 
studies 
248 per 
1,000 
491 per 1,000 OR 2.93  
(1.48 to 5.81) 
162  
(1 study) 
Secondary 
transmission, use of 
masks in homes, only 
RCTs 
121 per 
1,000  
 
 
114 per 1,000 
(86 to 150)  
OR 0.93 
(0.68 to 1.28)  
2078 
(2 RCTs)  
⨁⨁◯◯ 
LOW f,h 
  
House-mates wearing masks once 
another household member has 
contracted ILI may modestly reduce the 
odds of further household members 
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 Table 2. Summary of GRADE findings   
 Masks compared to no masks for influenza-like illness 
 Patient or population: people without ILI, either in contact with a person with ILI (secondary transmission) or not (primary 
prevention).  Setting: Any.  Intervention (or exposure): Advice to wear a mask and/or provision of masks (or wearing a mask).  
Comparison: No advice to wear a mask/advice to not wear masks (or not wearing a mask). 
Setting (outcome 
always ILI) 
 Anticipated absolute 
effects* (95% CI)  
Relative effect 
(95% CI)  
№ of 
participants  
(studies)  
Quality  
of the 
evidence 
(GRADE)  
Comments Study type  Risk 
without 
masks 
Risk with 
masks 
well person(s) wears 
mask  
  
Cohort studies  45 per 
1,000 
53 per 1,000  OR 1.04  
(0.05 to 19.52) 
163 (1 study) 
becoming ill by around 7%. Low quality 
evidence (downgraded twice overall for 
risk of bias, imprecision and 
inconsistency). 
Case control 
studies 
337 per 
1,000 
329 per 1,000 OR 0.96  
(0.50 to 1.86) 
162 (1 study) 
Secondary 
transmission, use of 
masks in homes, both 
well and ill person(s) 
wear mask  
RCT 
192 per 
1,000 
 
 
173 per 1,000 
(121 to 242) 
OR 0.81 
(0.48 to 1.37) 
1605 
(5 RCTs) 
⨁⨁◯◯ 
LOW h,i,j 
Both house-mates and the infected 
household member wearing masks once 
one household member has contracted 
ILI may modestly reduce the odds of 
further household members becoming 
ill by around 19%. Low quality evidence 
(downgraded twice overall for risk of 
bias, imprecision and inconsistency). 
Case control 
studies 173 per 
1,000 
86 per 1,000 
OR 0.45  
(0.18 to 1.05) 
191 (1 study) 
 *The risk in the intervention group (and its 95% confidence interval) is based on the assumed risk in the comparison group and the 
relative effect of the intervention (and its 95% CI).  CI: Confidence interval; OR: Odds ratio  
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 Table 2. Summary of GRADE findings   
 Masks compared to no masks for influenza-like illness 
 Patient or population: people without ILI, either in contact with a person with ILI (secondary transmission) or not (primary 
prevention).  Setting: Any.  Intervention (or exposure): Advice to wear a mask and/or provision of masks (or wearing a mask).  
Comparison: No advice to wear a mask/advice to not wear masks (or not wearing a mask). 
Setting (outcome 
always ILI) 
 Anticipated absolute 
effects* (95% CI)  
Relative effect 
(95% CI)  
№ of 
participants  
(studies)  
Quality  
of the 
evidence 
(GRADE)  
Comments Study type  Risk 
without 
masks 
Risk with 
masks 
 GRADE Working Group grades of evidence 
High quality: We are very confident that the true effect lies close to that of the estimate of the effect 
Moderate quality: We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the 
effect, but there is a possibility that it is substantially different 
Low quality: Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the 
effect 
Very low quality: We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the 
estimate of effect  
Explanations 
a. Risk of bias: Outcome assessors were not blinded for ILI (as outcomes are self-reported and participants could not be blinded), but were for lab-based diagnoses 
(not shown). Allocation concealment often unclear. Downgraded once.  
b. Inconsistency: I2 was 19%. Evidence from other study designs were roughly confirmatory of a small beneficial effect. Not downgraded.  
c. Indirectness: measured exactly what we wanted to know re primary prevention. Not downgraded.  
d. Imprecision: the 95% CIs included both benefits and harms. Downgraded once.  
e. Publication bias: no suggestion of publication bias, not downgraded.  
f. Risk of bias: In most trials outcome assessors were not blinded (as outcomes are self-reported and participants could not be blinded), and allocation concealment was 
often unclear. Downgraded once.  
g. Imprecision: the 95% CIs included both big benefits and big harms. Downgraded twice.  
h. Imprecision: the 95% CIs included both benefits and harms. Downgraded once.  
i. Risk of bias: In most trials outcome assessors were not blinded (as outcomes were self-reported and participants could not be blinded). Downgraded once in conjunction 
with inconsistency.  
j. Inconsistency: I2 was 53%. Downgraded in conjunction with Risk of Bias (downgraded once between both factors).  
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Prevention of primary infection, subgrouping by study design 
Figure 2 shows grouping of results by study design. Pooled data are presented to calculate a single 
odds ratio to compare and contrast study designs. Risk of biases for RCTs are also presented.  
The three RCTs which measured the prevention of primary infection, indicated a slight, non-
significant, reduction in the odds of primary infection with ILI (OR 0.94, 95%CI 0.60-1.07). 
Heterogeneity was low (I2 29%).   
 
Evidence from the five cohort comparisons suggested facemasks provided some primary protection 
(OR 0.85, 95%CI 0.32-2.27), although these findings were not significant. Heterogeneity was very 
high (I2 = 96%) and the men-only cohort from Choudhry et al.  [40] was a noticeable outlier. This set 
of studies included observational data based on actual facemask wearing habits from one study 
originally designed as an RCT [36].  
 
Among four case control (OR 0.39, 95%CI 0.18-0.84, I2 77%)  and eight cross-sectional studies (OR 
0.61, 95%CI 0.45-0.85, I2 95%), pooled data suggested that facemask wearing was protective, but 
effects were highly heterogeneous. Of the cross-sectional studies, Tahir et al.  [49] and Zein  [54] 
were noticeable outliers. Removal of these outliers still indicates facemask wearing as protective, 
although no longer significant, and heterogeneity falls slightly (OR 0.89, 95%CI 0.78-1.01, I2 = 64%, 
data not shown). 
 
Two studies on primary prevention did not provide suitable data for pooling.   Gautret et al. 2011 
[57] gave no data but reported that they had done analysis supporting their conclusions to comment 
narratively that facemasks were protective against respiratory tract infections.  Another study 
without reported original data, Hashim et al. 2016 [44], concluded that respirators were not 
effective protection against ILI.  
 
GRADE assessment suggested that wearing a mask may slightly reduce the odds of primary infection 
with influenza-like illness (ILI) by around 6 to 15%. (i.e. somewhere between the effects seen in RCTs 
and the effects seen in cohort studies; likely to be the most robust of the observational studies). This 
was low-quality evidence (downgraded once each for risk of bias and imprecision). 
 
Prevention of primary infection by exposure setting 
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Figure 3 groups results by exposure setting. Pooling of data from different study designs is not 
appropriate to calculate a single odds ratio statistic. Most results favoured facemask wearing.  
 
Facemask wearing was mostly protective (the midpoint-estimates of most included studies favoured 
facemask wearing) in the general community (3 cohort and 2 case control of which 2 studies were 
significantly protective), university residences (2 cluster-randomised RCTs, neither significant at p = 
0.05) and in schools (2 cross-sectional studies, neither significantly protective).   
 
One case control study for visits to health care clinics without a known index patient suggested that 
mask-wearing was significantly protective against primary infection.   One case control study on air 
travel suggested a protective but non-significant relationship between mask-wearing and avoiding 
infection. 
 
The results were less consistent (the point-estimates showed both protective and non-protective 
relationships) for animal contact (2 cross-sectional studies, 1 significant protective finding) and 
suggested masks were mostly not significant in getting or avoiding disease when used at mass 
gatherings (all Hajj pilgrims; 1 cluster-randomised RCT, 2 cohort, 1 case control and 3 cross-sectional; 
2 significant protective findings. 
 
 
Prevention of primary infection among face veil wearers 
Figure 4 shows data from two studies (cross-sectional and cohort) examining case incidence among 
women who wore face veils often/always while on Hajj pilgrimage. Both studies indicate a protective 
but non-significant relationship. 
 
 
Secondary transmission 
Figure 5 shows results for secondary transmission subdivided by study design and who wore the 
facemask (index patient, well contacts or both). Presented are pooled data to calculate a single odds 
ratio and risk of biases for each study design.  Findings from the two RCTs when only infected 
persons wore a facemask, suggested a very small, non-significant protective effect (OR 0.95, 95%CI 
0.53 to 1.72, I2 0%). The GRADE assessment suggested that the effect of the infected person wearing 
a facemask was unclear due to very low quality evidence (downgraded once for risk of bias, twice for 
imprecision).  
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The protective effect was very small if only the well people wore facemasks (OR 0.93, 95% CI 0.68 to 
1.28, I2 11%, 2 RCTs).  The GRADE assessment combining data from the two RCTs, and single cohort 
and case-control studies suggested low quality evidence. House-mates wearing masks once another 
household member has contracted ILI may modestly reduce the odds of further household members 
becoming ill by around 7%. Low quality evidence (downgraded twice overall for risk of bias, 
imprecision and inconsistency). 
 
Pooled data from five RCTs where both infected and non-infected household members wore 
facemasks showed the odds of infection fell modestly and not significantly (OR 0.81, 95%CI 0.48 to 
1.37, I2 45%).     
 
Findings from the one case control study [27] where both infected and non-infected household 
members wore facemasks indicated a large risk reduction but this was not significant at p < 0.05 (OR 
0.45, 95%CI 0.18 to 1.10).  Zhang et al 2013b. [56]  is a case control study that separated results for 
facemask wearing by whether masks were worn by either index patient or contacts.  These results 
significantly favoured no mask wearing by index patients ( OR 2.93, 95%CI 1.48 to 5.81) and found 
negligible attack rate differences between case and control households when contacts wore masks 
(OR 0.96, 95%CI 0.5 to 1.86). The final comparison in Figure 5 draws data from a single cohort study 
[50] where 95% of contacts never wore masks during contact with confirmed SARS-CoV-1 cases.  No 
significant effect from mask-wearing (or not) was found (OR 1.04, 95%CI 0.05-19.52). 
 
GRADE assessment for these 5 RCTs and one case-control study suggested that both house-mates 
and the infected household member wearing masks once one household member has contracted ILI 
may modestly reduce the odds of further household members becoming ill by around 19%. This was 
low quality evidence (downgraded twice overall for risk of bias, imprecision and inconsistency). 
 
Secondary transmission and early commencement of facemask wearing 
Figure 6 shows results for the four secondary transmission RCT studies providing data for attack 
rates when facemask wearing started < 36 hours after index patient became symptomatic. A single 
odds ratio statistic and risk of biases for RCTs are presented.  Facemask wearing was not protective 
in this subgroup analysis (OR 1.36, 0.66-2.79, I2 0%). Some of the original investigators in these 
studies undertook logistic regression to adjust their findings for other confounders and found 
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evidence that early facemask wearing (< 36 hours after symptom onset) could be protective, but 
acknowledged that their models were underpowered. 
 
 
Quality of Evidence  
Many of the included RCTs reported that participants did not follow instructions about wearing 
facemasks [19, 24, 25, 29, 36, 47].  Several reported that some controls wore facemasks during the 
monitoring period [25, 30, 47], while many intervention participants did not wear facemasks the 
majority of the time [24-26, 29, 47].  All of the RCTs included in our review provided specific 
facemasks (usually surgical grade, rarely P2 or equivalent grade respirator) with instructions on how 
to wear the facemask, how often they should be changed and how to hygienically dispose of used 
facemasks.   No information was reported about the types of facemasks that (contrary to protocol) 
some controls in RCTs used.  Very few of the observational studies collected information about what 
type of face covering was used.  Several studies highlight potential problems of recall bias [27, 49, 
53]. Other studies note that potential confounding factors were not explored [38, 43, 56]. 
 
Apart from studies conducted during the Hajj, the evidence base for primary transmission in specific 
settings such as public transport, schools, cafeterias and shops was minimal (Figure 3).  The only 
mass-gathering setting where facemask wearing evidence has been gathered and published is the 
Hajj.  
 
 
DISCUSSION 
The quality of the evidence is problematic.   We believe that RCT evidence under-estimated efficacy 
while observational studies have over-estimated how protective facemask wearing can be because 
of un-measured co-factors that cause confounding. For example, those who choose to wear masks 
may be more risk averse in general so undertake many protective activities alongside wearing a 
mask. Therefore, specific accurate estimates of the degree of protectiveness of facemasks from the 
currently available evidence base are unreliable. Our best estimate is that the effect of wearing a 
facemask is between the effects seen in RCTs and the effects seen in cohort studies, or around 6 to 
15% reduction in disease transmission. 
 
Lack of evidence on transmission in specific settings is also problematic, given that effectiveness is 
likely to differ between settings, and infection control measures will need to vary by setting.  The 
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evidence is arguably insufficient to comment meaningfully on primary transmission reduction in any 
setting other than the Hajj.  It is not ideal that the only mass gathering event studied is the Hajj 
which is exceptional for high contact rates over 10-20 days and which attracts a narrow demographic 
(older and relatively wealthy individuals)  [41, 44, 54, 57, 58].   These features are unlike many other 
mass gatherings.      
 
Producing clear evidence from observational and randomised studies that facemasks are effective 
(or not) in slowing COVID-19 spread would be desirable.  Only one of the studies included in this 
review were about people exposed to potential SARS-CoV-2 infection  [43].  There has sometimes 
been resistance to wearing face coverings, recommended or mandated to try to slow spread of 
COVID-19 [59, 60].  These tense conflicts seem likely to undermine all public health measures 
intended to slow the spread of COVID-19.  This situation underscores the need to produce reliable 
and clear primary research.   
 
Population level studies that consider COVID-19 spread before and after mask-wearing policies (and 
combinations of other control measures) were introduced in various localities [61-65]  have more 
often than not concluded that mask-wearing mandates or recommendations seemed to accelerate 
epidemic decline in early 2020.  Analyses of impacts of non-pharmaceutical interventions (NPI) in the 
COVID-19 pandemic are preliminary and some have been criticised for indirect measurements, use 
of selective data and inappropriate analytical methods [66-68].   Compliance information is also not 
usually included in these natural experiment studies.  It is not clear why population studies have 
tended to show definitive findings on mask-wearing which are not reflected in primary research.  
Aligning findings from the different evidence bases, and establishing a secure consensus about which 
NPI measures are effective, would be desirable and also might illuminate less recognised 
transmission pathways and best opportunities for risk reduction. 
 
While RCTs may underestimate effects of facemasks, because of compliance problems in both 
intervention and control groups, compliance with mask wearing seems very likely to be partial in real 
life, too.  This problem reflects a wider issue around public health interventions. Archie Cochrane 
himself pointed out “the gulf, which has been much under-estimated, between the scientific 
measurements based on RCTs and the benefit measurement in the community” [69].  There are in 
fact two questions here. The first is do facemasks, if used appropriately, reduce the risk of 
transmission from an infected individual and/or protect an uninfected person if in the presence of 
someone with COVID-19. The second question is whether public health interventions that require or 
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encourage people to wear face coverings actually achieve their objective of reducing diseases in the 
wider population. It is this later question that is the most important and the answer remains unclear.  
 
 
Limitations 
Due to the rapidity of this review we did not consider other article archives or databases such as 
Google Scholar, CINAHL and medRXiv.   Our search terms were designed to be more specific than 
they were sensitive.  We addressed all types of respiratory symptoms and diagnoses; in reality, 
transmission pathways even among respiratory viruses do vary somewhat individually.   A good 
reason to generate a larger evidence base is to make it possible to meaningfully separate pathogens 
and outcomes. “Mask” had to be among title/abstract/key words, and we are aware that “mask” 
was more likely to be among the title/abstract/key words if mask-wearing was linked to significant 
effects.  In practice, the search strategy meant that our search terms were slightly biased into finding 
articles where masks had been protective rather than having no effect.  We also considered only 
dichotomous outcomes; we did not classify outcomes by severity of symptoms or other clinical 
outcomes [70]. It is possible that facemask wearing reduced duration or severity of symptoms 
experienced due to reducing infectious dose received, although not actual disease.   
 
We did not undertake cost-benefit analysis. The sudden emergence of COVID-19 led to high 
community demand for face barriers and raised valid concerns that insufficient supplies of 
facemasks were available for health care workers [9, 10]. The environmental and economic costs of 
regularly using facemasks are notable, and only partly abated by reuse.  Other efforts have been 
made to calculate the balance of all benefits and costs in facemask wearing for disease prevention 
[71-74]. 
 
We make no comment on the relative utility of other proposed protective measures compared to 
facemask wearing, such as self-isolation or frequent handwashing: we have not undertaken research 
on those measures for comparison. We did not formally assess likelihood of publication bias in the 
primary research evidence base. 
 
 
CONCLUSIONS 
Original primary research is needed on whether and to what extent facemasks reduce transmission 
of COVID-19 and other respiratory communicable diseases.   Future RCT investigations should 
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explore methods to enhance compliance in both intervention and control participants and ensure 
these are reported. All studies should also report information about the types of facemasks people 
wore (in both control and intervention arms), frequency of wear and the range of other protective 
measures used.  It would be helpful to understand how masks were used by research participants, if 
masks were washed, disinfected or how they were disposed of, as well as duration of wear.  Future 
observational studies should carefully collect information on and adjust for key confounders.  
Research needs to be sensitive to settings and types of contact as well as the specific disease.  The 
impact of when mask wearing starts and type of prevention (eg., primary, early or later secondary 
prevention) needs investigating further, and is likely to differ between diseases.  This is especially 
true if studies can be well powered to produce more definitive results, or if evidence should emerge 
about facemask use within homes before symptom onset or within a very short period (perhaps 4-12 
hours) after symptom onset. 
 
 
 
SUPPLEMENTAL See Table S1 for extra characteristics of included studies. 
 
 
FIGURE CAPTIONS and NOTES 
 
Figure 1. Study selection process 
Figure 2. Mask wearing to prevent primary infection, by study design 
Figure 3. Mask wearing to prevent primary infection, by exposure setting 
Figure 4. Faceveil wearing to prevent primary infection 
Figure 5. Mask wearing to prevent secondary infection, transmission mostly within households 
Figure 6. Mask wearing to prevent secondary infection starting < 36 hours after onset in index 
patient, transmission within households 
 
Notes for all Figures: 
Notes: CI: confidence interval; df: degrees of freedom; ILI: influenza-like illness; intvn: intervention; 
M-H: Mantel-Haenszel, RCT: randomized controlled trial.  See Table 1 for study setting, study design, 
outcome, comparison (when not allocated arms in RCTs) and any concurrent other intervention in 
both study arms. 
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